miR-140 inhibits osteosarcoma progression by impairing USP22-mediated LSD1 stabilization and promoting p21 expression
Osteosarcoma is a bone tumor frequently diagnosed in children and young adults. Despite advances in chemotherapy and surgical resection, tumors metastasize in 30% of osteosarcoma patients. In addition, side effects caused by chemotherapeutic drugs, as well as the development of chemoresistance, high...
Saved in:
Main Authors: | Wei Liu (Author), Dunwei Wang (Author), Lidi Liu (Author), Lin Wang (Author), Ming Yan (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Clinical Significance of miR-21 in Guiding Chemotherapy for Patients with Osteosarcoma
by: Li LZ, et al.
Published: (2021) -
miR-140-3p is a potential differential biomarker in benign phyllodes tumors and fibroadenoma of the breast
by: Qiang Li, et al.
Published: (2022) -
Expression of miR-664-3p in Osteosarcoma and Its Effects on the Proliferation and Apoptosis of Osteosarcoma Cells
by: Ye LI, et al.
Published: (2019) -
MAFG-driven osteosarcoma cell progression is inhibited by a novel miRNA miR-4660
by: Hua-jian Shan, et al.
Published: (2021) -
Retraction Note: MiR-140 targets RAP2A to enable the proliferation of insulin-treated ovarian granulosa cells
by: Zhengfang Xiong, et al.
Published: (2023)